Health Canada approves first clinical trial for potential COVID-19 vaccine
Prime Minister Justin Trudeau said Saturday that Health Canada has authorized the first clinical trial for a potential COVID-19 vaccine at Dalhousie University in Nova Scotia.
The National Research Council of Canada will work with the manufacturers so that if these vaccine trials are successful, Canada can produce and distribute it within the country.
Dr. Scott Halperin, director of the Canadian Center for Vaccinology at Dalhousie University, said the approval for the phase one clinical trial was exciting news.
Halperin said it’s expected the first study using less than 100 healthy volunteers between the ages of 18 and 55 would likely get underway within the next three weeks.